A two-day Indo-US symposium on ‘Methodology of Research in Indian Systems of Medicine’, inaugurated on Wednesday, focused on research for validation of Ayurveda, Siddha and Unani for authorisation in the global market. Participants stressed on evaluating traditional medicines and strategically launching them in the global market. The symposium will also provide a platform for the traditional medicine industry to showcase its strengths and approaches in clinical research and manufacturing.
Speaking on the occasion, Prof Ikhlas A Khan, director of FDA programme at the University of Mississippi and director, Centre for Research in Indian Systems of Medicine (CRISM), said that positioning the traditional medicines in the global market required careful planning and support from the government. He said that scientists at CRISM were developing Ayurveda, Unani, Siddha herbal and botanical products of global standards and positioning them in the US and other developed countries. “Traditional healing has been used for over 1000 years in our country in itself is a testimony of their efficacy and safety. But since there is no documentation of those experiments and methodologies available, there is a need to develop sound scientific methodology of research in these systems, aiming at finding empirical evidence to validate various concepts and strengths,” said Shakir Jamil, director-general, Central Council for Research in Unani Medicine (CCRUM).
The symposium is being organised by CRISM, CCRUM,department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy.
Comments